EX-10.1 2 kala-20180630ex1013daa12.htm EX-10.1 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. Fourth Amendment to Exclusive License AgreementExclusive License Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020This Fourth Amendment to Exclusive License Agreement (the “Fourth Amendment”) is entered into by and between The Johns Hopkins University, a Maryland corporation having an address at 1812 Ashland Avenue, Suite 100, Baltimore, MD 21205 (“JHU”) and Kala Pharmaceuticals, Inc., a Delaware corporation having an address at 100 Beaver Street, Suite 201, Waltham, MA 02453 (“Kala” or “Company”).
Fourth Amendment to Exclusive License AgreementExclusive License Agreement • August 9th, 2018 • Kala Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 9th, 2018 Company IndustryThis Fourth Amendment to Exclusive License Agreement (the “Fourth Amendment”) is entered into by and between The Johns Hopkins University, a Maryland corporation having an address at 1812 Ashland Avenue, Suite 100, Baltimore, MD 21205 (“JHU”) and Kala Pharmaceuticals, Inc., a Delaware corporation having an address at 100 Beaver Street, Suite 201, Waltham, MA 02453 (“Kala” or “Company”).